These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20059824)

  • 21. Morphologic alterations of Anaplasma marginale in calves after treatment with oxytetracycline.
    Simpson CF
    Am J Vet Res; 1975 Oct; 36(10):1443-6. PubMed ID: 1190584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outbreak of anaplasmosis associated with the presence of different Anaplasma marginale strains in dairy cattle in the states of São Paulo and Goiás, Brazil.
    Machado RZ; da Silva JB; André MR; Gonçalves LR; Matos CA; Obregón D
    Rev Bras Parasitol Vet; 2015; 24(4):438-46. PubMed ID: 26648009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined treatment with a dithiosemicarbazone and oxytetracycline to eliminate Anaplasma marginale infections in splenectomized calves.
    Kuttler KL
    Res Vet Sci; 1972 Nov; 13(6):536-9. PubMed ID: 4648995
    [No Abstract]   [Full Text] [Related]  

  • 24. Isolation of a bovine Theileria.
    Kuttler KL; Craig TM
    Am J Vet Res; 1975 Mar; 36(3):323-5. PubMed ID: 804831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects and use of a modified live Anaplasma marginale vaccine in beef heifers in California.
    Henry ET; Norman BB; Fly DE; Wichmann RW; York SM
    J Am Vet Med Assoc; 1983 Jul; 183(1):66-9. PubMed ID: 6874525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frozen and fresh Anaplasma centrale vaccines in the protection of cattle against Anaplasma marginale infection.
    Abdala AA; Pipano E; Aguirre DH; Gaido AB; Zurbriggen MA; Mangold AJ; Guglielmone AA
    Rev Elev Med Vet Pays Trop; 1990; 43(2):155-8. PubMed ID: 2092348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of three methods of immunization against bovine anaplasmosis: an examination of postvaccinal effects.
    Corrier DE; Vizcaino O; Carson CA; Ristic M; Kuttler KL; Treviño GS; Lee AJ
    Am J Vet Res; 1980 Jul; 41(7):1062-5. PubMed ID: 7436099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance to anaplasmosis after elimination of latent Anaplasma marginale infections.
    Richey EJ; Brock WE; Kliewer IO; Jones EW
    Am J Vet Res; 1977 Feb; 38(2):169-70. PubMed ID: 557302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical chemistry of anaplasmosis: blood chemical changes in infected mature cows.
    Allen PC; Kuttler KL; Amerault TE
    Am J Vet Res; 1981 Feb; 42(2):322-5. PubMed ID: 7258783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroprevalence of anaplasmosis among cattle in Switzerland in 1998 and 2003: no evidence of an emerging disease.
    Dreher UM; Hofmann-Lehmann R; Meli ML; Regula G; Cagienard AY; Stärk KD; Doherr MG; Filli F; Hässig M; Braun U; Kocan KM; Lutz H
    Vet Microbiol; 2005 Apr; 107(1-2):71-9. PubMed ID: 15795079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inhibitory effect of imidocarb on experimental anaplasmosis in splenectomized calves.
    Roby TO
    Res Vet Sci; 1972 Nov; 13(6):519-22. PubMed ID: 4648992
    [No Abstract]   [Full Text] [Related]  

  • 32. Protection in the absence of exclusion between two Brazilian isolates of Anaplasma marginale in experimentally infected calves.
    Bastos CV; Passos LM; Facury-Filho EJ; Rabelo EM; Fuente Jde L; Ribeiro MF
    Vet J; 2010 Dec; 186(3):374-8. PubMed ID: 19837622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of a new oxytetracycline formulation against clinical anaplasmosis.
    Magonigle RA; Simpson JE; Frank FW
    Am J Vet Res; 1978 Sep; 39(9):1407-10. PubMed ID: 697150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative efficacy of drugs in bovine anaplasmosis.
    Mishra AK; Sharma NN
    Trop Anim Health Prod; 1979 Nov; 11(4):222-6. PubMed ID: 552672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bovine anaplasmosis: susceptibility of seronegative cows from an infected herd to experimental infection with Anaplasma marginale.
    Lincoln SD; Zaugg JL; Maas J
    J Am Vet Med Assoc; 1987 Jan; 190(2):171-3. PubMed ID: 3818429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of blood parasites in cattle from wilayates of Annaba and El Tarf east Algeria.
    Ziam H; Benaouf H
    Arch Inst Pasteur Tunis; 2004; 81(1-4):27-30. PubMed ID: 16929762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of an attenuated Anaplasma marginale vaccine in Mexico natural challenge of immunity in an enzootic area.
    Osorno MB; Solana PM; Perez JM; Lopez TR
    Am J Vet Res; 1975 May; 36(5):631-3. PubMed ID: 1137209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative efficacy of oxytetracycline and a dithiosemicarbazone in eliminating Anaplasma marginale infection in splenectomized calves.
    Kuttler KL; Adams LG
    Res Vet Sci; 1970 Jul; 11(4):339-42. PubMed ID: 5499317
    [No Abstract]   [Full Text] [Related]  

  • 39. Anaplasma marginale infection in young and aged cattle.
    Jones WE; Kliewer IO; Norman BB; Brock WE
    Am J Vet Res; 1968 Mar; 29(3):535-44. PubMed ID: 5688978
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of estrogens upon Anaplasma marginale infection in splenectomized cattle.
    Klaus G; Jones EW; Kliewer IO
    Am J Vet Res; 1967 Jul; 28(125):1033-6. PubMed ID: 6065933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.